Valeant Pharmaceuticals International Inc (VRX): Today's Featured Drugs Loser

The drugs industry closed the day up 0.7%. DARA Biosciences Inc ( DARA), Neptune Technologies & Bioressources Inc ( NEPT), Horizon Pharma Inc ( HZNP), and Galena Biopharma Inc ( RXII) were all decliners today within the drugs industry with Valeant Pharmaceuticals International Inc ( VRX) being today's featured drugs loser. Valeant Pharmaceuticals International Inc fell 23 cents (-0.7%) to $35.30 on light volume. Throughout the day, 2.4 million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.4 million shares.

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $10.4 billion and is part of the health care sector.

TheStreet Ratings rates Valeant Pharmaceuticals International as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and disappointing return on equity.

On the positive front, Aoxing Pharmaceutical Company Inc ( AXN), Cormedix Inc ( CRMD), China Shenghuo Pharmaceutical Holdings Inc ( KUN), and Tibet Pharmaceuticals Inc ( TBET) were all gainers within the drugs industry with Teva Pharmaceutical Industries ( TEVA) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).

null

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again